News
NIH’s Steven Ferguson will be speaking at the Licensing Executives Society (LES) upcoming virtual seminar titled Industry, Universities, and Government – How to Work Together Through Contracts. This seminar will take place on June 25, 2024 from 10am-1pm EST. “The interface between institutions doing
Inventors at the National Institute of Dental and Craniofacial Research (NIDCR) are searching for a collaboration partner for a tissue engineering method for treating cartilage damage. Currently, there are no effective treatment options approved to prevent arthritis progression. This method involves
The Public Health and Economic Impact Study of NIH Intramural Technology Transfer Licensing final project report has been published. This report dives into the history of biomedical innovations that were a result of the NIH Intramural Research Program (IRP) that benefit the United States. This
A novel anti-cancer therapy to target the Proviral Integration of the Moloney murine leukemia virus (PIM) kinases is available for licensing and co-development. PIM kinases are overexpressed in many solid cancers, which is predictive of poor survival in multiple cancer types. NIH inventors have